Scholarlink

Background <p>Second-generation antihistamines are widely used for the management of allergic conditions. In addition, many second-generation antihistamines are readily available over the counter at pharmacies. However, the effects of these medications on driving performance when subtasks are involved remain unclear.</p> Objective <p>This study investigated the impact of second-generation antihistamines—known for their reduced sedative effects compared with first-generation antihistamines—on driving performance. Specifically, we aimed to quantify the class-level effect of second-generation antihistamines on driving performance under everyday conditions—including periods with and without conversational subtasks—and to test whether performance decrements are greater during subtask than non-subtask periods.</p> Method <p>Participants (<i>N</i> = 21; mean age 34.6 ± 7.73 years) completed a driving-simulator task under four within-subject conditions (2 × 2): with vs. without a subtask and while taking vs. not taking a second-generation antihistamine (fexofenadine, bepotastine, levocetirizine, ketotifen, or desloratadine). Driving performance was assessed across six predefined events under each condition.</p> Results <p>The findings revealed that, on average, the class-level effect of second-generation antihistamines on driving performance was minimal, regardless of the driving events. However, although statistical significance was not reached, the data showed a consistent trend suggesting that performing subtasks while taking second-generation antihistamines may increase driving risk across all events.</p> Conclusion <p>At the class level, second-generation antihistamines exert minimal effects on overall driving performance; nevertheless, concurrent subtasks (e.g., conversation) may diminish safety margins. While not definitive, these exploratory findings support heightened caution during everyday multitasking and motivate larger, sex-balanced studies to confirm and characterize medication–subtask interactions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects of second generation antihistamines on daily driving with and without subtasks measured in a driving simulator

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月28日

查看全文
  • Akihito Nagahama,
  • Atsunobu Sagara,
  • Hayato Aki,
  • Hiroki Yoshimura,
  • Makoto Hiraide,
  • Takatsune Shimizu,
  • Motohiko Sano,
  • Tetsuro Yumoto,
  • Tomoo Hosoe,
  • Kenji Tanaka

摘要

Background

Second-generation antihistamines are widely used for the management of allergic conditions. In addition, many second-generation antihistamines are readily available over the counter at pharmacies. However, the effects of these medications on driving performance when subtasks are involved remain unclear.

Objective

This study investigated the impact of second-generation antihistamines—known for their reduced sedative effects compared with first-generation antihistamines—on driving performance. Specifically, we aimed to quantify the class-level effect of second-generation antihistamines on driving performance under everyday conditions—including periods with and without conversational subtasks—and to test whether performance decrements are greater during subtask than non-subtask periods.

Method

Participants (N = 21; mean age 34.6 ± 7.73 years) completed a driving-simulator task under four within-subject conditions (2 × 2): with vs. without a subtask and while taking vs. not taking a second-generation antihistamine (fexofenadine, bepotastine, levocetirizine, ketotifen, or desloratadine). Driving performance was assessed across six predefined events under each condition.

Results

The findings revealed that, on average, the class-level effect of second-generation antihistamines on driving performance was minimal, regardless of the driving events. However, although statistical significance was not reached, the data showed a consistent trend suggesting that performing subtasks while taking second-generation antihistamines may increase driving risk across all events.

Conclusion

At the class level, second-generation antihistamines exert minimal effects on overall driving performance; nevertheless, concurrent subtasks (e.g., conversation) may diminish safety margins. While not definitive, these exploratory findings support heightened caution during everyday multitasking and motivate larger, sex-balanced studies to confirm and characterize medication–subtask interactions.